annual EBITDA:
$63.12M-$43.48M(-40.79%)Summary
- As of today (May 21, 2025), ANIP annual EBITDA is $63.12 million, with the most recent change of -$43.48 million (-40.79%) on December 31, 2024.
- During the last 3 years, ANIP annual EBITDA has risen by +$60.01 million (+1925.71%).
- ANIP annual EBITDA is now -40.79% below its all-time high of $106.60 million, reached on December 31, 2023.
Performance
ANIP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$48.36M+$33.51M(+225.60%)Summary
- As of today (May 21, 2025), ANIP quarterly EBITDA is $48.36 million, with the most recent change of +$33.51 million (+225.60%) on March 31, 2025.
- Over the past year, ANIP quarterly EBITDA has increased by +$3.74 million (+8.38%).
- ANIP quarterly EBITDA is now at all-time high.
Performance
ANIP quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$66.86M+$3.74M(+5.93%)Summary
- As of today (May 21, 2025), ANIP TTM EBITDA is $66.86 million, with the most recent change of +$3.74 million (+5.93%) on March 31, 2025.
- Over the past year, ANIP TTM EBITDA has dropped by -$59.80 million (-47.21%).
- ANIP TTM EBITDA is now -47.21% below its all-time high of $126.66 million, reached on March 31, 2024.
Performance
ANIP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ANIP EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -40.8% | +8.4% | -47.2% |
3 y3 years | +1925.7% | +1123.1% | +544.6% |
5 y5 years | +3.9% | +1343.2% | +53.0% |
ANIP EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -40.8% | +1925.7% | at high | +460.4% | -47.2% | +544.6% |
5 y | 5-year | -40.8% | +1925.7% | at high | +460.4% | -47.2% | +544.6% |
alltime | all time | -40.8% | +224.3% | at high | +295.0% | -47.2% | +216.1% |
ANIP EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $48.36M(+225.6%) | $66.86M(+5.9%) |
Dec 2024 | $63.12M(-40.8%) | $14.85M(-210.7%) | $63.12M(-10.0%) |
Sep 2024 | - | -$13.42M(-178.6%) | $70.16M(-39.9%) |
Jun 2024 | - | $17.07M(-61.8%) | $116.69M(-7.9%) |
Mar 2024 | - | $44.62M(+103.9%) | $126.66M(+18.8%) |
Dec 2023 | $106.60M(+325.7%) | $21.89M(-33.9%) | $106.60M(+4.4%) |
Sep 2023 | - | $33.12M(+22.5%) | $102.07M(+28.6%) |
Jun 2023 | - | $27.04M(+10.1%) | $79.34M(+46.0%) |
Mar 2023 | - | $24.56M(+41.6%) | $54.33M(+117.0%) |
Dec 2022 | $25.04M(+703.6%) | $17.35M(+67.0%) | $25.04M(-596.9%) |
Sep 2022 | - | $10.39M(+413.2%) | -$5.04M(-42.2%) |
Jun 2022 | - | $2.02M(-142.8%) | -$8.72M(-42.0%) |
Mar 2022 | - | -$4.73M(-62.9%) | -$15.04M(-582.6%) |
Dec 2021 | $3.12M(-88.9%) | -$12.73M(-289.6%) | $3.12M(-88.4%) |
Sep 2021 | - | $6.71M(-256.3%) | $26.92M(-21.1%) |
Jun 2021 | - | -$4.30M(-132.0%) | $34.13M(-10.7%) |
Mar 2021 | - | $13.43M(+21.3%) | $38.20M(+35.8%) |
Dec 2020 | $28.13M(-53.7%) | $11.07M(-20.5%) | $28.13M(+28.8%) |
Sep 2020 | - | $13.93M(-6291.6%) | $21.84M(-11.5%) |
Jun 2020 | - | -$225.00K(-106.7%) | $24.68M(-43.5%) |
Mar 2020 | - | $3.35M(-29.9%) | $43.71M(-28.0%) |
Dec 2019 | $60.73M(-11.4%) | $4.78M(-71.5%) | $60.73M(-19.7%) |
Sep 2019 | - | $16.77M(-10.9%) | $75.61M(-2.5%) |
Jun 2019 | - | $18.81M(-7.7%) | $77.52M(+4.4%) |
Mar 2019 | - | $20.38M(+3.7%) | $74.25M(+8.3%) |
Dec 2018 | $68.55M(+21.7%) | $19.65M(+5.2%) | $68.55M(+8.3%) |
Sep 2018 | - | $18.68M(+20.2%) | $63.30M(+3.5%) |
Jun 2018 | - | $15.55M(+6.0%) | $61.14M(+2.5%) |
Mar 2018 | - | $14.67M(+1.9%) | $59.67M(+6.0%) |
Dec 2017 | $56.31M(+33.0%) | $14.40M(-12.9%) | $56.31M(+15.0%) |
Sep 2017 | - | $16.52M(+17.4%) | $48.98M(+5.7%) |
Jun 2017 | - | $14.08M(+24.4%) | $46.32M(+6.8%) |
Mar 2017 | - | $11.31M(+60.1%) | $43.38M(+2.4%) |
Dec 2016 | $42.35M(+6.8%) | $7.07M(-49.0%) | $42.35M(-3.0%) |
Sep 2016 | - | $13.87M(+24.5%) | $43.66M(+8.4%) |
Jun 2016 | - | $11.14M(+8.4%) | $40.27M(+3.4%) |
Mar 2016 | - | $10.28M(+22.6%) | $38.96M(-1.7%) |
Dec 2015 | $39.64M(+64.9%) | $8.38M(-20.0%) | $39.64M(-8.8%) |
Sep 2015 | - | $10.47M(+6.5%) | $43.48M(+2.6%) |
Jun 2015 | - | $9.83M(-10.3%) | $42.39M(+37.6%) |
Mar 2015 | - | $10.96M(-10.3%) | $30.81M(+28.0%) |
Dec 2014 | $24.04M(+1311.9%) | $12.21M(+30.1%) | $24.07M(+55.8%) |
Sep 2014 | - | $9.39M(-635.1%) | $15.45M(+112.9%) |
Jun 2014 | - | -$1.75M(-141.5%) | $7.26M(+34.8%) |
Mar 2014 | - | $4.23M(+17.7%) | $5.38M(-695.7%) |
Dec 2013 | $1.70M(-106.3%) | $3.59M(+201.3%) | -$903.60K(-89.0%) |
Sep 2013 | - | $1.19M(-132.9%) | -$8.25M(-47.1%) |
Jun 2013 | - | -$3.63M(+76.2%) | -$15.59M(-18.8%) |
Mar 2013 | - | -$2.06M(-45.1%) | -$19.20M(-29.5%) |
Dec 2012 | -$27.23M | -$3.75M(-39.0%) | -$27.25M(-9.0%) |
Sep 2012 | - | -$6.15M(-15.0%) | -$29.95M(-17.5%) |
Jun 2012 | - | -$7.24M(-28.4%) | -$36.33M(-13.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2012 | - | -$10.11M(+56.7%) | -$42.11M(-14.1%) |
Dec 2011 | -$50.78M(+12.0%) | -$6.45M(-48.5%) | -$49.04M(-14.9%) |
Sep 2011 | - | -$12.53M(-3.8%) | -$57.62M(+2.4%) |
Jun 2011 | - | -$13.02M(-23.6%) | -$56.29M(+5.3%) |
Mar 2011 | - | -$17.04M(+13.4%) | -$53.46M(+17.9%) |
Dec 2010 | -$45.34M(+18.4%) | -$15.03M(+34.2%) | -$45.34M(-17.7%) |
Sep 2010 | - | -$11.20M(+9.8%) | -$55.11M(+13.0%) |
Jun 2010 | - | -$10.20M(+14.4%) | -$48.78M(+13.0%) |
Mar 2010 | - | -$8.91M(-64.1%) | -$43.17M(+12.7%) |
Dec 2009 | -$38.29M(+113.1%) | -$24.80M(+409.6%) | -$38.29M(+149.6%) |
Sep 2009 | - | -$4.87M(+6.1%) | -$15.34M(-10.6%) |
Jun 2009 | - | -$4.59M(+13.7%) | -$17.15M(-5.1%) |
Mar 2009 | - | -$4.03M(+118.0%) | -$18.06M(+0.4%) |
Dec 2008 | -$17.97M(+109.2%) | -$1.85M(-72.3%) | -$17.99M(-0.8%) |
Sep 2008 | - | -$6.68M(+21.4%) | -$18.14M(+33.5%) |
Jun 2008 | - | -$5.50M(+39.0%) | -$13.59M(+27.1%) |
Mar 2008 | - | -$3.96M(+97.6%) | -$10.69M(+24.5%) |
Dec 2007 | -$8.59M(-341.5%) | -$2.00M(-5.9%) | -$8.59M(-354.7%) |
Sep 2007 | - | -$2.13M(-18.2%) | $3.37M(-27.7%) |
Jun 2007 | - | -$2.60M(+40.2%) | $4.66M(-6.7%) |
Mar 2007 | - | -$1.86M(-118.6%) | $5.00M(+40.5%) |
Dec 2006 | $3.56M(-138.7%) | $9.96M(-1290.2%) | $3.56M(-143.5%) |
Sep 2006 | - | -$836.80K(-63.1%) | -$8.17M(-11.8%) |
Jun 2006 | - | -$2.27M(-31.2%) | -$9.27M(-4.0%) |
Mar 2006 | - | -$3.30M(+86.5%) | -$9.65M(+4.9%) |
Dec 2005 | -$9.20M(-24.4%) | -$1.77M(-8.5%) | -$9.20M(-20.8%) |
Sep 2005 | - | -$1.93M(-27.3%) | -$11.62M(-7.9%) |
Jun 2005 | - | -$2.66M(-6.5%) | -$12.61M(+0.4%) |
Mar 2005 | - | -$2.84M(-32.0%) | -$12.56M(+3.2%) |
Dec 2004 | -$12.16M(+104.3%) | -$4.18M(+42.9%) | -$12.16M(+25.3%) |
Sep 2004 | - | -$2.93M(+12.4%) | -$9.70M(+18.5%) |
Jun 2004 | - | -$2.60M(+6.3%) | -$8.19M(+13.9%) |
Mar 2004 | - | -$2.45M(+42.1%) | -$7.19M(+20.6%) |
Dec 2003 | -$5.95M(+60.1%) | -$1.72M(+21.7%) | -$5.96M(+28.9%) |
Sep 2003 | - | -$1.42M(-11.7%) | -$4.63M(+16.0%) |
Jun 2003 | - | -$1.60M(+31.4%) | -$3.99M(+3.2%) |
Mar 2003 | - | -$1.22M(+214.8%) | -$3.87M(+3.8%) |
Dec 2002 | -$3.72M(+39.0%) | -$387.90K(-50.1%) | -$3.73M(-21.7%) |
Sep 2002 | - | -$777.80K(-47.4%) | -$4.76M(+29.6%) |
Jun 2002 | - | -$1.48M(+36.9%) | -$3.67M(+21.7%) |
Mar 2002 | - | -$1.08M(-23.8%) | -$3.02M(+14.9%) |
Dec 2001 | -$2.68M(-19.3%) | -$1.42M(-560.6%) | -$2.62M(+38.0%) |
Sep 2001 | - | $307.80K(-137.3%) | -$1.90M(-33.6%) |
Jun 2001 | - | -$825.40K(+19.8%) | -$2.87M(-16.9%) |
Mar 2001 | - | -$689.00K(-0.9%) | -$3.45M(+6.0%) |
Dec 2000 | -$3.31M(+118.9%) | -$695.00K(+6.0%) | -$3.25M(+27.2%) |
Sep 2000 | - | -$655.80K(-53.5%) | -$2.56M(+34.5%) |
Jun 2000 | - | -$1.41M(+186.4%) | -$1.90M(+139.2%) |
Mar 2000 | - | -$492.30K(+62.5%) | -$795.30K(+162.5%) |
Dec 1999 | -$1.51M(-39.9%) | - | - |
Jun 1999 | - | -$303.00K | -$303.00K |
Dec 1998 | -$2.52M | - | - |
FAQ
- What is ANI Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual EBITDA year-on-year change?
- What is ANI Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly EBITDA year-on-year change?
- What is ANI Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM EBITDA year-on-year change?
What is ANI Pharmaceuticals annual EBITDA?
The current annual EBITDA of ANIP is $63.12M
What is the all time high annual EBITDA for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual EBITDA is $106.60M
What is ANI Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, ANIP annual EBITDA has changed by -$43.48M (-40.79%)
What is ANI Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of ANIP is $48.36M
What is the all time high quarterly EBITDA for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly EBITDA is $48.36M
What is ANI Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, ANIP quarterly EBITDA has changed by +$3.74M (+8.38%)
What is ANI Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of ANIP is $66.86M
What is the all time high TTM EBITDA for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM EBITDA is $126.66M
What is ANI Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, ANIP TTM EBITDA has changed by -$59.80M (-47.21%)